Acute infection requiring systemic antibiotics, antivirals, or antifungals within two weeks prior to first dose
Acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior cycle , day 
Acute active infection requiring systemic antibiotics, antivirals, or antifungals within two weeks prior to first dose
Acute active infection requiring systemic antibiotics, antivirals, or antifungals within  days prior to first dose
Serious infection requiring oral or IV antibiotics/antifungals/antivirals and/or hospitalization within  days prior to screening\r\n* Patients on prophylactic oral antibiotics, antifungals and antivirals due to prolonged neutropenia in the absence of documented infection are eligible\r\n* Patients who are treated with IV antibiotics for neutropenic fever, are eligible if no infectious etiology was determined and the last dose of antibiotics was >=  days from cycle , day 
Uncontrolled infection requiring systemic antibiotics/antivirals/antifungals
Acute infection requiring systemic antibiotics, antivirals, or antifungals within two weeks prior to first dose
Treatment with intravenous (systemic antibiotics, antivirals, or antifungals) within  days prior to start of treatment
Chronic or current active infectious disease requiring systemic antibiotics, antifungals, or antivirals
Acute infection requiring treatment (IV antibiotics, antivirals, or antifungals) within  days prior to initiation of study
Acute infection requiring systemic anti-infectives, antivirals, or antifungals within two weeks prior to first dose
Must not have acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to enrollment.
Acute infection requiring systemic antibiotics, antivirals, or antifungals within  days prior to first dose
Patients who have an acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to registration are NOT eligible for participation
Ongoing or active infection; treatment with systemic antibiotics or antifungals for ongoing or recurrent infection (topical use of antibiotics or antifungals is allowed)
Clinically relevant active infection requiring treatment (antibiotics, antivirals, antifungals)
Acute infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to initiation of study
Acute infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to initiation of study
Acute active infection requiring treatment (IV antibiotics, antivirals, or antifungals) within  days prior to the first day of treatment
Presence of an acute infection requiring active treatment with antibiotics/antivirals; prophylactic administration is allowed
No acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to cycle  day 
Acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to signing consent
Active infection requiring systemic antibiotics, antivirals, or antifungals within  weeks prior to first dose
Acute active infection requiring systemic antibiotics, antivirals, or antifungals within two weeks prior to first dose
Active infection (including HIV/acquired immune deficiency syndrome [AIDS], hepatitis B, or hepatitis C infection) requiring systemic antibiotics, antivirals, or antifungals
Acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to enrollment
Acute active infection requiring systemic antibiotics, antivirals, or antifungals within  days prior to first dose
Acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to randomization
Acute active infection requiring systemic antibiotics, antivirals, or antifungals within  days prior to first dose
Acute active infection requiring treatment (systemic antibiotics, antivirals, or antifungals) within  days prior to randomization
Have an active, clinically significant serious infection requiring intravenous treatment with antibiotics, antivirals, or antifungals.